References
- Bräuner-Osborne H, Egebjerg J, Nielsen Eø, Madsen U, Krogsgaard-Larsen P. Ligands for glutamate receptor: design and therapeutic prospects. J Med Chem (2000); 43:2609.
- Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev (1999); 51:7.
- Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci (1994); 17:103.
- Lees GJ. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders. Drugs (2000); 59:33.
- Madsen U, Stensbøl TB, Krogsgaard-Larsen P. Inhibitors of AMPA and kainate receptors. Curr Med Chem (2001); 81:291.
- Nikam SS, Kornberg BE. AMPA receptor antagonists. Curr Med Chem (2001); 8:155.
- Stensbøl TB, Madsen U, Krogsgaard-Larsen P. The AMPA receptor binding site: focus on agonists and competitive antagonists. Curr Pharm Des (2002); 8:857.
- Auberson YP. Competitive AMPA antagonism: a novel mechanism for antiepileptic drugs. Drugs Fut (2001); 26:463.
- Donevan SD, Rogawski M. GYKI 52466, a 2, 3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron (1993); 10:51.
- Tortorella A, Halonen T, Sahibzada N, Gale K. A crucial role of the α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptors in piriform and perirhinal cortex for the initiation and propagation of limbic motor seizures. J Pharmacol Exp Ther (1997); 280:1401.
- Löscher W. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog Neurobiol (1998); 54:721.
- Löscher W, Lehmann H, Behl B, Seemann D, Teschendorf HJ, Hofmann HP, Lubisch W, Hoger T, Lemaire HG, Gross G. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy. Eur J Neurosci (1999); 11:250.
- Desraju GR, Gopalakrishnan B, Jetti RK, Nagarjun A, Raveendra D, Sarma JA, Sobhia ME, Thiagavathi R. Computer-aided design of selective cox-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivatives. J Med Chem (2002); 45:4847.
- TBohm M, Sturzebecher J, Klebe G. Three dimensional quantitative structure activity relationship analysis using comparative molecular field analysis and comparative molecular similarity search analysis to elucidate selectivity differences of inhibitor binding to trypsin, thrombin and factor Xa. J Med Chem (1999); 42:458.
- Catarzi D, Colotta V, Varano F, Cecchi L, Filacchioni G, Galli A, Costagli C, Carla V. 7-Chloro-4-5-dihydro-8-(1,2,4-triazole-4-yl)-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carbo-xylates as novel highly selective AMPA receptor antagonists. J Med Chem (2000); 43:3824.
- Catarzi D, Colotta V, Varano F, Cecchi L, Filacchioni G, Calabri VR, Galli A, Costagli C, Carla V. Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4-oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a] quinox-aline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists. J Med Chem (2004); 47:262.
- Catarzi D, Colotta V, Varano F, Cecchi L, Filacchioni G, Galli A, Costagli C, Carla V. Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a] quinoxaline-2-carboxylates analogues of TQX-173. J Med Chem (2001); 44: 3157.
- Varano F, Catarzi D, Colotta V, Filacchioni G, Galli A, Costagli C, Carla V. Synthesis and biological evaluation of a new set of pyrazolo [1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists. J Med Chem (2002); 45:1035.
- Cheng YC, Prusoff WH. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol (1973); 22:3099.
- Sybyl ver. 6.9, Tripos Inc., St. Louis, (MO) USA.